July 10, 2014 3:44 PM ET

Pharmaceuticals

Company Overview of Hoffmann-La Roche Inc.

Executive Profile

George B. Abercrombie R.Ph., MBA

Senior Vice President of Corporate Partnerships & Commercial, Theravance Inc.
AgeTotal Calculated CompensationThis person is connected to 4 Board Members in 4 different organizations across 10 different industries.

See Board Relationships
59--

Background

Mr. George B. Abercrombie, R.Ph., MBA, has been Senior Vice President of Corporate Partnerships & Commercial at Theravance Inc. since June 2014. Mr. Abercrombie has more than 30 years experience as a Business Leader in the pharmaceutical industry. He has substantial expertise in sales and marketing, executive sales management and business development. Mr. Abercrombie served as the Chief Executive Officer and President of Roche Laboratories, Inc. Mr. Abercrombie served ...

Corporate Headquarters

340 Kingsland Street
Nutley, New Jersey 07110

United States

Phone: 973-235-5000
Fax: 973-777-3327

Board Members Memberships

Former Director
Chairman
2010-Present
Director and Member of Audit Committee
2010-2010
Former Director, Member of Nominating Committee, Member of Compensation Committee and Member of Nominating and Corporate Governance Committee
2011-Present
Non-Executive Chairman, Member of Audit Committee, Member of Corporate Governance & Nominating Committee and Member of Compensation Committee
2011-N/A
Director and Member of Nominating & Corporate Governance Committee
2013-Present
Director

Education

MBA
Harvard Business School
BS
University Of North Carolina At Chapel Hill

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Howard W. Robin Chief Executive Officer, President and Director
Nektar Therapeutics
$831.2K
Peter M. Hecht Ph.D. Co-Founder, Chief Executive Officer and Director
Ironwood Pharmaceuticals, Inc.
$100.0K
Mark R. Baker J.D.Chief Executive Officer, Director and Member of Science & Strategy Committee
Progenics Pharmaceuticals, Inc.
$535.6K
Peter S. Greenleaf Chief Executive Officer, Director, Member of Commercialization Committee and Member of Science & Technology Committee
Sucampo Pharmaceuticals, Inc.
--
Richard Martin Steeves BSc., Ph.D.Group Chief Executive Officer, Member of Senior Executive Board and Executive Director
Synergy Health plc
$823.0K
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Hoffmann-La Roche Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.